Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder / Joel Raskin en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - PP. 32-38 Título : Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder Tipo de documento: texto impreso Autores: Joel Raskin, Autor ; Curtis G. Wiltse, Autor ; James J. Dinkel, Autor Fecha de publicación: 2023 Artículo en la página: PP. 32-38 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor, Tiofenos - administración y dosificación Resumen: To compare the safety and tolerability profile of duloxetine versus placebo in elderly (≥65 years) patients with major depressive disorder (MDD). Patients were randomized (2:1) to duloxetine 60 mg/d (once daily) (n = 207) or placebo (n = 104) for 8 weeks. Safety and tolerability measures were analyzed in the total cohort of patients, as well as in subgroups defined by age and preexisting hypertension. Link: ./index.php?lvl=notice_display&id=30870 [artículo] Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder [texto impreso] / Joel Raskin, Autor ; Curtis G. Wiltse, Autor ; James J. Dinkel, Autor . - 2023 . - PP. 32-38. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - PP. 32-38 Palabras clave: Antidepresivos, Trastorno depresivo mayor, Tiofenos - administración y dosificación Resumen: To compare the safety and tolerability profile of duloxetine versus placebo in elderly (≥65 years) patients with major depressive disorder (MDD). Patients were randomized (2:1) to duloxetine 60 mg/d (once daily) (n = 207) or placebo (n = 104) for 8 weeks. Safety and tolerability measures were analyzed in the total cohort of patients, as well as in subgroups defined by age and preexisting hypertension. Link: ./index.php?lvl=notice_display&id=30870

---

1 (1 - 1 / 1)